Stay updated on ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.

Latest updates to the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4. This reflects a minor site update without changes to the study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating an update to the page content. It does not appear to modify the study details or other substantive content.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a maintenance or deployment change rather than a modification to the study record.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded Ewing sarcoma and Malignant fibrous histiocytoma to the page's conditions/keywords.SummaryDifference0.1%

- Check83 days agoChange DetectedAngiosarcoma was added as a MeSH term and a 2026 publication (IMMUNOSARC II Master Trial) was added to Publications; the previous revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to ImmunoSarc: Sarcoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ImmunoSarc: Sarcoma Immunotherapy Clinical Trial page.